Dan Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dan Zhou has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Caiyun Qian
Department of Blood Transfusion, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication- Daya Luo
The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Jiangxi Medical College, Nanchang University, Nanchang, 330031, China.
1 shared publication - Jiayi Zhang
School of Queen Mary, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication - Renzhuo Gao
School of Queen Mary, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication - Xiaohong Yang
School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication - Xingpeng Qiu
School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by SAGE Publications in Cancer Control
- Vol. 31
Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review
Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.
- 1 January 2024
- Published by SAGE Publications in Cancer Control
- Vol. 31
Open AccessCancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review
Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.